Acer Reports September Consolidated Revenues of NT$29.53 Billion, Highest in 11 Years; Up 35.4% Month-on-month and 12.2% Year-on-year
TAIPEI, Oct. 9, 2025 /PRNewswire/ — Acer Inc. (TWSE: 2353) announced its consolidated revenues for September at NT$29.53 billion, marking the highest in 11... Read more.
Jacobs Launches Cloud-Based Modeling Platform
Now available as subscription software to unify and streamline flood modeling Supports faster, data-driven decisions on infrastructure flood resilience DALLAS, Oct.... Read more.
ON2IT Launches breakthrough MDR Detect™: The Real MDR, Delivering Clarity, Control, and Disruptive Pricing in Minutes
PLANO, Texas and AMSTERDAM, Oct. 9, 2025 /PRNewswire/ — ON2IT, a global innovator in Zero Trust cybersecurity, announces the release of MDR Detect™- the... Read more.
Invitation to Vitrolife Group’s presentation of the Q3 2025 interim report
GOTHENBURG, Sweden, Oct. 9, 2025 /PRNewswire/ — Vitrolife AB (publ) will publish its Q3 2025 interim report on Thursday, 23 October 2025 at 08:00 am CEST.... Read more.
Focus Group Names Intermedia as Strategic Partner to Deliver AI-Powered, Fully Integrated Communications Solutions Across the UK
SUNNYVALE, Calif. and WEST SUSSEX, England, Oct. 9, 2025 /PRNewswire/ — Focus Group, one of the UK’s leading independent providers of essential business... Read more.
Ideoli Group Partners with European Soccer Legend Theodoros Zagorakis to Illuminate ZAGORAKIS7 ACADEMY with Advanced LED Stadium Lighting
ATHENS and THESSALONIKI, Greece, Oct. 9, 2025 /PRNewswire/ — Ideoli Group, recognised globally as a leader in lighting innovation, is proud to announce its... Read more.
Sumsub Releases 2nd Global Fraud Index In Collaboration With Statista, Studying Fraud Trends Across 100+ Countries
Index reveals that Europe leads in fraud protection, while the U.S. and many Asian countries see major declines. LONDON, Oct. 9, 2025 /PRNewswire/ — Today, Sumsub,... Read more.
Resolution Therapeutics announces upcoming presentations at the American Association for the Study of Liver Disease (AASLD) The Liver Meeting® 2025
– Dr Paul Brennan to present on the association of early biomarker modulation with long term clinical outcomes from the MATCH Ph II study of non-engineered macrophages... Read more.
ARTHEx Biotech to Participate in Upcoming Investor and Industry Events
Valencia, Spain, Oct. 9, 2025 /PRNewswire/ — ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing targeted RNA medicines for rare... Read more.
Aker Carbon Capture ASA: Trading suspension from ex-date 13 October 2025
FORNEBU, Norway, Oct. 9, 2025 /PRNewswire/ — Reference is made to the extraordinary general meeting of Aker Carbon Capture ASA (under liquidation) (the “Company”)... Read more.